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ABSTRACT
Background
Streptococcus suis serotype 2 (S. suis 2, SS2) is a major zoonotic pathogen that causes only
sporadic cases of meningitis and sepsis in humans. Most if not all cases of Streptococcal toxic
shock syndrome (STSS) that have been well-documented to date were associated with the non-
SS2 group A streptococcus (GAS). However, a recent large-scale outbreak of SS2 in Sichuan
Province, China, appeared to be caused by more invasive deep-tissue infection with STSS,
characterized by acute high fever, vascular collapse, hypotension, shock, and multiple organ
failure.
Methods and Findings
We investigated this outbreak of SS2 infections in both human and pigs, which took place
from July to August, 2005, through clinical observation and laboratory experiments. Clinical and
pathological characterization of the human patients revealed the hallmarks of typical STSS,
which to date had only been associated with GAS infection. Retrospectively, we found that this
outbreak was very similar to an earlier outbreak in Jiangsu Province, China, in 1998. We isolated
and analyzed 37 bacterial strains from human specimens and eight from pig specimens of the
recent outbreak, as well as three human isolates and two pig isolates from the 1998 outbreak
we had kept in our laboratory. The bacterial isolates were examined using light microscopy
observation, pig infection experiments, multiplex-PCR assay, as well as restriction fragment
length polymorphisms (RFLP) and multiple sequence alignment analyses. Multiple lines of
evidence confirmed that highly virulent strains of SS2 were the causative agents of both
outbreaks.
Conclusions
We report, to our knowledge for the first time, two outbreaks of STSS caused by SS2, a non-
GAS streptococcus. The 2005 outbreak was associated with 38 deaths out of 204 documented
human cases; the 1998 outbreak with 14 deaths out of 25 reported human cases. Most of the
fatal cases were characterized by STSS; some of them by meningitis or severe septicemia. The
molecular mechanisms underlying these human STSS outbreaks in human beings remain
unclear and an objective for further study.
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Streptococcus suis is responsible for a variety of diseases in
pigs, including meningitis, septicemia, arthritis, pneumonia,
and even acute death, causing great economic loss in the pig
industry worldwide every year [1,2]. So far, 35 different
serotypes of S. suis have been identiﬁed based on variation in
the capsular antigens [2]. S. suis serotype 2 (S. suis 2 or SS2) is
the most frequently isolated serotype worldwide, and it
comprises pathogenic, weakly pathogenic, and nonpathogen-
ic strains [1–4]. Various bacterial components such as
extracellular and cell membrane–associated proteins have
been suggested as virulence-associated factors, but their
precise roles in the pathogenesis or virulence of S. suis have
not been established [3,4]. Currently, attempts to control the
diseases caused by S. suis are still hampered by the lack of
sufﬁcient knowledge of pathogenesis mechanisms. Besides
causing disease in pigs, S. suis 2 can also cause serious enzootic
infections in humans, which are associated with septicemia,
meningitis, and endocarditis [5]. There have been nearly 200
cases of S. suis 2 infection in humans worldwide since the ﬁrst
case of meningitis was recorded in Denmark in 1968 (China
CDC, http://www.chinacdc.net.cn). Streptococcal toxic shock
syndrome (STSS) refers to severe human invasive infection
caused by Streptococcus pyogenes (S. pyogenes), a member of the
group A streptococci (GAS) [6–8] (Note, the abbreviation of
STSS originally referred to staphylococcal toxic shock
syndrome [TSS] and was borrowed later for TSS caused by
S. pyogenes). Most invasive GAS disease occurs sporadically, but
recent years have seen a rise of cases reported worldwide [9–
11]. GAS produces many toxins responsible for the clinical
manifestations seen in infected patients. Some of them,
labeled streptococcal pyrogenic exotoxins, have been char-
acterized as superantigens [12,13]. More recently, M protein, a
constituent of the cell wall of S. pyogenes, has been found to be
an important virulent factor and implicated in the patho-
logical mechanism of STSS [14,15].
STSS caused by non-GAS streptococci, including group B
streptococci, group C streptococci, and group G streptococci,
has not been well documented [16,17]. Here we describe two
recent outbreaks of S. suis 2, a non-GAS, in China and
characterize the STSS they caused in human patients.
Methods
Clinical Observations
Faced with an unknown human infection outbreak in June
2005, in Ziyang County, Sichuan Province, China, we formed
a team to investigate the event and to provide a compre-
hensive characterization of the patients. As we recognized the
similarity to an earlier outbreak in 1998, we also analyzed
retrospective data and analyzed stored samples from that
outbreak. All work on autopsy samples (including the
immunohistochemistry experiments described below) was
carried out with written consent from relatives and approved
by the Sichuan Provincial CDC ethics committee.
Isolation and Identification of the Pathogen
To uncover the cause of the mysterious outbreak, blood,
liver, and spleen samples were collected from the affected
swine and humans. To isolate a possible bacterial pathogen,
several selective media (Protocol S1) [18] were utilized to
propagate inoculums from these samples. Subsequently,
Gram staining was performed according to the standard
protocol [18], and the resultant slides were observed under an
optical microscope. Candidate isolates were grown in Todd-
Hewitt broth (THB, code CM189; Oxoid, Basingstoke,
Hampshire, United Kingdom) for genomic DNA isolation,
and plated on Columbia agar blood base (code CM331;
Oxoid) containing 6% (vol/vol) sheep blood to differentiate
their haemolytic types [18].
Light and Electron Microscopy of Pathological Sections
To study pathological changes of the patients with S. suis 2–
caused STSS, we used light microscopy for initial observa-
tions. Liver and spleen tissues from the autopsy specimen
were selected to prepare sections for further transmission
electron microscopy (TEM) observation (Protocol S1).
Immunohistochemistry Experiments
To examine details of the pathological changes and detect
speciﬁc antigens in the infected tissues, immunohistochem-
istry was applied to formalin-ﬁxed parafﬁn-embedded liver
sections (Protocol S1). Primary antibodies (anti–S. suis 2
serum derived from the recovered pig infected by S. suis 2)
Table 1. General Description of Human Cases from the 2005
Outbreak of SS2 Infections
Clinical Types Fatal Cases Cases Where
Patients Survived
Cases Proportion (%) Cases Proportion (%)
STSS 37 97.4 22 13.3
Meningitis 1 2.6 103 62.0
Others
a 0 0.0 41 24.7
Total number 38 100.0 166 100.0
STSS fatal cases are indicated in bold.
aOthers, patients who had neither STSS nor meningitis. Most of them had septicemia and confirmed
infection with S. suis 2. All had close contact with ill or dead pigs.
DOI: 10.1371/journal.pmed.0030151.t001
Table 2. Details of Human Cases from the 2005 Outbreak of SS2
Infections
Parameter Value Clinical Types of Disease
STSS Meningitis Others
a
Sex Male 50 90 31
Female 9 14 10
Age ;20 0 0 2
;30 2 13 4
;40 16 15 7
;50 25 47 17
;60 10 21 5
;70 6 8 6
Average age 55 54 53
Fatality 37 1 0
Recovery 22 103 41
Average incubation (d) 1.9 (n ¼ 42) 2.5 (n ¼ 59) 2.7 (n ¼ 24)
Recovery time in the
hospital (d)
16.7 15.9 10.3
aOthers, patients who had neither STSS nor meningitis. Most of them had septicemia and confirmed
infection with S. suis 2. All had close contact with ill or dead pigs.
DOI: 10.1371/journal.pmed.0030151.t002
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STSS by S. suis 2and normal pig serum were used at a dilution of 1:50. The
Histo-stain Plus Kit (Zymed Laboratories, South San Fran-
cisco, United States) was used for detection. Sections were
brieﬂy counterstained with haematoxylin.
Pig Infection Experiments
To test the pathogenicity of the bacterium agent, infection
experiments were performed in pigs [19,20] (Protocol S1).
The challenged piglets were monitored for clinical signs of
the disease every 3 h. Bacterial pathogens were recovered
from those piglets that showed marked signs of illness or had
died 30 h post-infection. All experiments were conducted in a
biosafety level 3 (BSL-3) facility and approved by the local
Sichuan Provincial CDC ethics committee.
Mitogenicity Activity Test to Search for Superantigens
To determine the mechanism by which potential super-
antigens might be produced by S. suis 2, mitogenicity activity
was tested in human PBMCs [21,22] (Protocol S1).
Qualitative PCR Assay
Routine genomic DNA preparations from all the isolates
were done as described [23]. Multiplex-PCR (multi-PCR)
assays were developed as described [24–26]. Six pairs of
primers speciﬁc for the target genes (including 16S rDNA,
glutamate dehydrogenase [gdh], extracellular protein factor
[epf], mrp, suilysin, and cps-2J) were designed (listed in Table S1).
Multi-PCR assays were performed using a PTC-225 thermo-
cycler (MJ Research, Waltham, Massachusetts, United States),
in a total volume of 50 ll. Genomic DNA from the R 735
strain of S. suis 2, provided by Marcelo Gottschalk in Canada,
was used as a positive control template.
RFLP Analysis of the Isolates
To test for potential genotypic differences among isolates
from both outbreaks, we carried out chromosomal EcoRI
digestion and RFLP analysis as previously described [23].
Amplification and Sequencing of the Target Genes
General PCR was performed to amplify the full-length
target genes encoding 16S rRNA and several virulence
associated factors for further sequence analysis. A series of
primers were designed to amplify the genes encoding 16S
rDNA (one fragment), gdh (one fragment), suilysin (one
fragment), ﬁbronectin binding protein (fbp), epf (ﬁve frag-
ments), muramidase release protein (mrp) (eight fragments),
and a gene cluster involved in CPS2 synthesis (12 putative
structural genes) (22 fragments) for sequencing by ABI 3730
DNA sequencer (Perkin-Elmer Applied Biosystems, Wellesley,
Massachusetts, United States). Data were assembled and
analyzed using Vector NTI Suite 8.0 software (Invitrogen,
Carlsbad, California, United States). Phylogenic trees were
constructed with MEGA 3.0 Software [27].
Results
Clinical Features of the Affected Patients
From June to August, 2005, an outbreak of severe invasive
infection in humans and pigs occurred in Ziyang County,
Sichuan Province, China, and attracted worldwide news
coverage. A total number of 204 human cases, with 38 deaths
(Table 1) were recorded (China CDC, http://www.chinacdc.net.
cn). The patients consisted of 198 farmers, ﬁve butchers, and
one veterinarian, and most of them were found to have skin
cuts on their hands and/or feet. Furthermore, they all had a
history of direct contact with ill or dead pigs before they
developed symptoms. No cases of human-to-human trans-
mission were observed in this outbreak (Table S2). The
outbreak was immediately recognized as a zoonotic disease,
because almost all the patients had been in contact with pigs,
and there was a concurrent disease outbreak among the local
pig population, with more than 640 pig fatalities. The disease
was clearly serious and associated with death in a substantial
fraction of patients (Table 2). In the fatal human cases, the
disease started with acute illness, malaise, fever, headache,
diarrhea, rapidly developing hyperpyrexia, hypotension, and
a decline of pulse pressure (Table 3). Erythematous blanching
rash was very obvious on the distal part of the extremities,
including blood spots and petechia (Table 3). All of these
symptoms are indicative of possible TSS. Coma was seen in
severe cases (Table 3). It was common for not only the white
blood cell count to be elevated (Table 4), but also for the
neutrophil cell count (data not shown). Ultimately, some cases
progressed to multisystem dysfunction, such as acute respi-
ratory distress syndrome (ARDS), liver failure, heart failure,
disseminated intravascular coagulation (DIC), and acute renal
failure (Table 3). These symptoms and the hematological
changes were in accordance with the clinical parameters of
STSS caused by GAS [28,29]. All but one of the 38 fatal cases
had STSS symptoms. One death was due to meningitis.
Patients with meningitis alone had fever, chills, headache,
vomiting, and meningism. Retrospectively, the clinical fea-
tures were extremely reminiscent of those associated with the
earlier outbreak in 1998 [30,31].
Identification and Characterization of the Pathogen
Based on the clinical features, we suspected that the
patients had bacterial TSS, and we sought to identify the
Table 3. Clinical Features of Human Cases in the 2005 Outbreak
of SS2 Infections
Symptoms Clinical Diseases in Humans
STSS
(n ¼ 59)
Meningitis
(n ¼ 104)
Others
a
(n ¼ 41)
Fever 59 (100.0%) 104 (100.0%) 41 (100.0%)
Chills 44 (74.6%) 87 (83.7%) 34 (82.9%)
Hypotension 56 (94.9%) 0 0
Erythematous blanching rash 56 (94.9%) 0 0
ARDS 49 (83.1%) 0 0
Diarrhea 28 (47.5%) 17 (16.3%) 4 (9.8%)
Renal function abnormal 48 (81.4%) 22 (21.2%) 9 (22.0%)
Liver function abnormal 46 (78.0%) 68 (65.4%) 15 (36.6%)
DIC 47 (79.7%) 0 0
Headache 29 (49.2%) 104 (100.0%) 31 (75.6%)
Vomiting 37 (62.7%) 61 (58.7%) 19 (46.3%)
Cough 10 (16.9%) 26 (25.0%) 0
Coma 50 (84.7%) 16 (15.4%) 0
Kernig’s sign 1 (1.7%) 26 (25.0 %) 0
Brudzinski’s sign 0 18 (17.3%) 0
Typical clinical features of STSS in bold. Meningitis was characterized by fever, chills, headache, vomiting,
and meningism.
aOthers, patients who had neither STSS nor meningitis cases. Most of them had septicemia and confirmed
infection with S. suis 2. All had close contact with ill or dead pigs.
DOI: 10.1371/journal.pmed.0030151.t003
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STSS by S. suis 2pathogenic bacteria. After two days of selective cultivation,
we observed enriched growth of isolates from tissue samples
of affected swine and human. On the agar plates with sheep
blood, the bacteria showed a-haemolysis typical of S. suis, with
the slightly gray or semitransparent, wet, and ropy colonies
surrounded by haemolytic circles of 2–3 lm in diameter [18].
A subsequent Gram’s stain experiment conﬁrmed that all
isolates were Gram-positive (GP
þP) cocci visible as short
chains under the light microscope (Figure 1A), suggesting that
they may belong to the genus Streptococcus.M u l t i - P C R
detection combined with direct DNA sequence analysis
(Protocol S1) was used to further determine the isolates’
identity. The results identiﬁed the isolates as S. suis 2, with ﬁve
putative virulence-factor genes, including gdh, mrp, epf, suilysin,
and cps-2J (Figure 1B). In total, we isolated and analyzed 37
strains from human specimens and eight from pig specimens.
We also performed an analysis of three human isolates and
two pig isolates from the 1998 outbreak and found exactly the
same results.
Pathological Changes in Dying Patients with STSS
To examine the pathological changes in patients dying of
the presumed STSS caused by this pathogen, light microscopy
was used, and more detailed pathological information was
obtained using TEM (Protocol S1). Both liver and spleen
exhibited tissue autolysis. However, hepatic lobule structure
and the tandem arrangement of the hepatic plates were
relatively normal (Figure 2A). Defuse degeneration of the
hepatic cells was also seen (Figure 2A), particularly in the
areas surrounding the central vein (Figure 2B). Hepatic cell
necrosis was also observed in this area (Figure 2B). The liver
sinuses were slightly dilated due to proliferation of sinus
histiocytes (Figure 2B), while the hepatic cells around the
convergent zone appeared unchanged (Figure 2C). Although
the structure of the spleen was also affected, both red and
white pulps were clearly visible, with some reduction of the
white pulps. Neither the liver nor the spleen showed obvious
signs of inﬂammation. The tissue autolysis affected the
cellular structures of the liver and spleen, but pathogenic
bacteria were visible inside the Kupffer cells of the liver
(Figure 2D) and the macrophages of the spleen. The bacteria
had oval shapes, 600–900 nm in length, and 280–580 nm in
diameter, and were surrounded by glycocalyx (Figure 2D). We
performed immunohistochemistry on parafﬁn-embedded
sections from the autopsy specimen, using sera from pigs
infected with S. suis 2 and healthy pigs as negative control,
Table 4. Haematology and Biochemistry of Different Clinical Diseases in Some of the Humans from the 2005 Outbreak of SS2
Infections
Index of Blood Examination Clinical Types of Disease in the
Human Cases (Median and Ranges)
STSS (n ¼ 34) Meningitis (n ¼ 39) Others
a (n ¼ 32)
White blood cells (10
9/L) 12.4 (9.4–23.3) 15.2 (11.6–31.1) 15.4 (10.8–20.6)
Creatinine (lmol/L) 249.4 (94.3–716.6) 92.4 (76.3–168.2) 78.7 (49.9–152.6)
Urea nitrogen (mmol/L) 14.6 (5.7–39.7) 6.3 (4.6–10.3) 4.6 (4.1–9.3)
Uric acid (lmol/L) 425.2 (148.6–992.5) 241.7 (165.1–483.4) 216.6 (162.1–456.1)
Aspartate aminotransferase (U/L) 436.5 (57.6–2,531.4) 69.7 (15.3–173.9) 42.5 (21.2–88.4)
Alanine aminotransferase (U/L) 216.8 (40.8–542.4) 42.7 (21.4–75.6) 34.8 (26.4–69.1)
Bilirubin total (lmol/L) 45.9 (25.1–144.8) 20.6 (15.1–36.7) 19.4 (5.8–29.8)
Bilirubin direct (lmol/L) 25.3 (14.3–105.4) 7.8 (6.1–15.4) 7.7 (2.4–14.9)
Indirect bilirubin (lmol/L) 20.6 (9.2–39.4) 12.8 (7.6–22.3) 11.7 (3.4–17.2)
All data were recorded for the patients when they were first hospitalized.
aOthers are patients who had neither STSS nor meningitis. Most of them had septicemia and confirmed infection with S. suis 2. All had close contact with ill or dead pigs.
DOI: 10.1371/journal.pmed.0030151.t004
Figure 1. Detection of the Pathogenic SS2 and Identification of Its Specific Genes
(A) Light microscopy image of the isolates cultured from autopsy specimens.
GP
þ cocci (pointed to with black arrows) are arranged in various short chains (3100).
(B) Qualitative PCR detection of isolates from the liver of fatal human cases with a set of primers specific for S. suis 2. M: 100bp DNA marker (Fermentas,
Vilnius, Lithuania). CK: 16S rDNA PCR product from the R 735 standard strain of S. suis 2. Multi-PCR: performed with a set of unique primers specific for
mrp, epf, suilysin, and cps-2J, respectively.
DOI: 10.1371/journal.pmed.0030151.g001
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STSS by S. suis 2respectively (Figure 3). The autopsy specimen contained
showed clearly visible positive brown particles in hepatic cells
and Kupffer cells near the central vein (Figure 3B), which
were absent the negative control sample (Figure 3A). All of
these results suggested some crucial physical and pathological
links between the STSS of the patients and S. suis 2.
Pathogenesis Assessment of S. suis 2
To test the virulence of the ﬁeld isolates, we infected SPF
mini-piglets (Guizhou line) with S. suis ZYH13 that we had
isolated from one of the fatal human cases of STSS. Two of
the piglets were intravenously injected and both died within
27 h. Two others were intranasally inoculated, and they
developed signs of severe illness (lamping, shivering high
temperature, CNS failure, and respiratory failure) within 28
h, and both died at day 10 post-infection. In contrast, four
piglets infected intravenously or intranasally (two each) with
S. suis 68, a weakly virulent strain isolated from a healthy pig,
all survived with only minor symptoms. Moreover, many GP
þP
cocci recovered from the tissue and blood of the infected pigs
that had subsequently died were conﬁrmed to be S. suis 2b y
optical microscopy and qualitative PCR detection assays.
Thus, the animal infection experiments conﬁrmed that these
isolates are highly pathogenic strains and supported the
conclusion that an invasive strain of S. suis 2 caused the STSS
symptoms associated with the human outbreaks.
Superantigen Test and Genotyping of S. suis 2
We failed to identify so-called superantigens in our isolates
(unpublished data), suggesting that the molecular mecha-
nisms by which S. suis 2 causes STSS might be different from
those of GAS [12,13]. RFLP analysis of the isolates from both
outbreaks conﬁrmed that they share a common genotype that
is different from that of S. suis S10, an international strain of
Figure 2. Microscopic Characterization of Sectioned Liver Tissue from Patients Who Had Died
(A) Light image of a liver tissue section (3100). The central vein is indicated with an arrow.
(B) Light image of a liver tissue section (3200).
(C) The convergent zone is indicated with an arrow (3100).
(D) TEM image of a liver tissue section (320,000). A bacterium found in the tissue is highlighted with an arrow.
DOI: 10.1371/journal.pmed.0030151.g002
Figure 3. Immunohistochemical Analysis of Liver Tissue Sections from Dead Patients Incubated with Normal and S. suis 2-Infected Swine Serum
(A) Staining with normal swine serum detected no S. suis 2 antigen.
(B) Staining with the serum from the infected swine indicated the presence of S. suis 2 antigen.
DOI: 10.1371/journal.pmed.0030151.g003
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STSS by S. suis 2high virulence, and may constitute an unique strain of S. suis 2
(Figure 4). Whole-genome sequencing of our isolates of S. suis
2 currently under way will help delineate the sequence
differences with S. suis S10 and might suggest how the isolates
cause STSS.
Examination of Virulence-Associated Factors
To further characterize the molecular features of the
isolates from the two outbreaks, and to compare them with
each other and with other unrelated isolates, we sequenced a
number of genes and constructed phylogenic trees. The
genes we analyzed included 16S rDNA, gdh, structural gene
clusters involved in capsule polysaccharide (CPS) synthesis (a
total of 12 genes from cps-2A to cps-2L), mrp, epf, suilysin, and
fbp. For the CPS gene clusters, both the current and 1998
isolates gave rise to a different pattern from the pattern for
S. suis P1/7, an international highly pathogenic strain (Figure
5), indicating speciﬁc characteristics shared by the S. suis 2
isolates from China. Five of 12 structural genes, including
cps2B, cps2D, cps2F, cps2K, and cps2L exactly matched those of
S. suis P1/7. In contrast, seven structural genes showed some
point variations. The divergent genes included cps2A (G163A,
F273I, and F302L), cps2C (I160V and Q195K), cps2E (G190E,
W264L, and S281C), cps2G (F183Y), cps2H (M268I and K300E),
cps2I (K145M), and cps2J (Q175K, R201S, S213G, L214I, and
Y223K).
The sequencing results of the partial 16S rDNA and GDH
(which has a possible role in pathogenesis [25,32]) further
conﬁrmed the identity of S. suis 2 of the isolates (Figure 6). All
other sequencing data also indicated that the isolates
represented a virulent strain of S. suis 2. Particularly EF,
the derivative of EF*, which lacks the repeated amino acid
units in the C-terminus and was initially described by Smith
et al. [33] and is indicative of high virulence, was found in all
our isolates. Phylogenic trees (Figure 6) showed that our four
isolates cluster together for one of the six genes we
examined, which suggests that the same pathogenic bacteria
might be involved in both outbreaks. Furthermore, the
isolates shared ﬁve putative pathogenesis islands with a
universal highly virulent S. suis P1/7. Taken together, our
results indicate that the same or closely related pathogenic
bacteria belonging to a highly virulent strain of S. suis 2 were
responsible for two recent outbreaks and can cause STSS in
humans.
Discussion
S. suis 2 is known worldwide for causing sporadic
meningitis and septicemia in pigs and humans who acquire
the infection through skin wounds [1,2,5]. The ﬁrst case of
human meningitis caused by S. suis 2 in Denmark was
reported in 1968. Prior to this study, we are aware of 198
cases of human S. suis infection worldwide, most of them
caused by S. suis 2 and associated with clinical symptoms of
meningitis or septicemia. However, this is to our knowledge
the ﬁrst detailed report in an international journal of STSS
caused by S. suis 2 in a large-scale outbreak.
We describe an S. suis 2–caused STSS in a substantial
number of human patients and a concurrent outbreak in pigs
in Sichuan Province, China, and include some data from a
similar outbreak in 1998 in Jiangsu Province, China. Our
diagnosis was based on the following criteria, which might be
useful for future identiﬁcation of similar outbreaks: sudden
onset of high fever; hypotension; blood spots and petechia;
Figure 4. RFLP Analysis of Different S. suis 2 Isolates
S. suis S10: a highly virulent strain from China; S. suis 9801: swine isolate
from Jiangsu Province in 1998; S. suis Habb: human isolate from Jiangsu
Province in 1998; S. suis ZYS3: swine isolate from Sichuan Province in
2005; S. suis ZYH13: human isolate from Sichuan Province in 2005; M: 1
kb DNA Ladder (MBI Ferments, Gdansk, Poland).
DOI: 10.1371/journal.pmed.0030151.g004
Figure 5. Comparison of the cps2 Gene Clusters Involved in CPS-2 Synthesis
Exactly matched genes (5/12) include cps2B, cps2D, cps2F, cps2K, and cps2L and are shown in pink. The seven other genes (which did not exactly match)
include cps2A cps2C, cps2E, cps2G, cps2H, cps2I, and cps2J and were highlighted with green in S. suis P1/7 and with red in both S. suis 98 and S. suis ZY.
Amino acid abbreviations used are: A, alanine; C, cysteine; E, glutamic acid; F, phenyalanine; G, glycine; I, isoleucine; K, lysine; L, leucine; M, methionine;
Q, glutamine; R, arginine; S, serine; V, valine; W, tryptophan; Y, tyrosine.
DOI: 10.1371/journal.pmed.0030151.g005
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STSS by S. suis 2clear erythematous blanching rash; and dysfunction of
multiple organs. Initially we speculated that there might be
some special molecular markers for those isolates compared
with standard strains. However, nearly all the candidate
pathogenesis islands or virulence markers of our isolates, i.e.,
GDH, MRP, EF, Suilysin, and FBP [25,32–38] matched exactly
those of S. suis P1/7 (Figure 6), suggesting that the genes are
conserved. Our data indicate that highly virulent strains of S.
suis 2–caused human STSS in two recent large-scale out-
breaks. However, the exact mechanism by which S. suis 2, a
non-GAS, causes STSS is yet to be unveiled.
For the CPS gene clusters, both the 2005 and the 1998
isolates gave rise to a pattern different from S. suis P1/7
(Figure 5), suggesting speciﬁc characteristics of the S. suis 2
isolates from China which could contribute to the high
virulence of the bacteria and their ability to cause human
STSS. However, additional experiments are needed to
examine a possible link between these genotypes and human
pathology.
Our detailed analysis of the S. suis 2 isolates allowed a
molecular diagnosis in the two outbreaks, and may help to
develop some diagnostic products for S. suis 2 in the future.
To our knowledge, this is the ﬁrst description of a large-
scale STSS outbreak among humans caused by a non-GAS
pathogen, S. suis 2. The molecular mechanisms in the
pathogen and the host underlying the outbreaks should be
addressed in future studies.
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Patient Summary
Background. Streptococcus suis (S. suis) is a bacterium that causes
disease in pigs. The bacterium is present in nearly all countries with an
extensive pig industry, and it can be transmitted between animals and
humans. Humans can be infected with S. suis when they have exposed
cuts and abrasions on their hands and handle infected pig carcasses and
meat. Human infection is rare but can be severe.
Why Was This Study Done? In 2005 there was a serious human disease
outbreak in Sichuan province in China that affected more than 100
people who had been working with pigs. It coincided with an outbreak
among the local pigs that had the hallmarks of being caused by S. suis
bacteria. The human outbreak, however, was unusual: it was larger than
any previous ones, many of the human patients died, and the symptoms
they had were somewhat different from what had been seen in previous
cases of human S. suis infection. This study represents the first detailed
scientific report of the human outbreak, including details of the patients
and of the bacteria that caused the outbreak. Such information is
essential for the global health community to keep tabs on infectious
disease outbreaks, and to work together to limit the threat of existing
and emerging pathogens.
What Did the Researchers Do and What Did They Find? They
collected hospital records and autopsy samples from human patients
and from pigs that had died during the outbreak. As they report, 204
human cases were documented during the outbreak, and 38 of those
patients died. Many of the infected patients, and almost all of the ones
who died, had the typical symptoms of a dangerous condition in which
the patient’s blood pressure drops (the condition is called Streptococcal
toxic shock syndrome, or STSS). Up to the date of this study, STSS had
only been documented in patients infected with Streptococcus
pyrogenes, also a member of the Streptococcus family of bacteria but
quite different from S. suis. However, the bacteria that the researchers
isolated from the human and pig samples were clearly of the S. suis type,
and they showed that the isolated bacteria could cause typical S. suis
disease in piglets. The researchers also examined the genetic material of
the S. suis from the outbreak to see whether it could explain why these
particular bacteria were able to cause STSS. However, they failed to
detect any of the genes that are present in S. pyrogenes and thought to
cause STSS. They also compared the genetic material from the S. suis
outbreak with other S. suis strains from around the world, including one
from an earlier, smaller S. suis outbreak in Jiangsu Province that had
killed 14 out of 25 patients in the reported human cases. The strains of S.
suis that caused the two Chinese outbreaks were more similar to each
other than to any other strains from elsewhere in the world.
What Does This Mean? The recent outbreak of a disease transmitted
from animals to humans, and in many cases deadly, is of global concern.
More experiments are necessary to see whether the size and high death
rate of the recent outbreak is because the Chinese S. suis version is a
particularly deadly strain, or because of other circumstances specific to
this outbreak. Future studies are urgently needed to better understand
the Chinese S. suis bacteria in detail. Doctors around the world should be
aware of the possibility of S. suis–associated STSS when they see sick,
feverish patients who have been in contact with pigs.
Where Can I Find More Information Online?
Pages from the UK Health Protection Agency on Streptococcus suis:
http://www.hpa.org.uk/infections/topics_az/zoonoses/strep_suis/menu.
htm
A short description of the 2005 of the S. suis outbreak in pigs on the
WHO Web site:
http://www.who.int/csr/don/2005_08_03/en/
WHO fact sheet on S. suis:
http://www.wpro.who.int/media_centre/fact_sheets/fs_20050802.htm
Pages on S. suis from the Hong Kong Centre for Health Protection:
http://www.chp.gov.hk/content.asp?langs¼en&info_id¼3648&id¼
24&pid¼9
Pages from the Chinese Center for Disease Control and Prevention:
http://www.chinacdc.net.cn/n272562 (English home page)
http://www.chinacdc.net.cn/n272442/n272530/index.html (Chinese
home page)
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